CVRx, Inc. (CVRX) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Minneapolis, MN, United States. The current CEO is Kevin Hykes.
CVRX has IPO date of 2021-06-30, 206 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $203.13M.
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
